S Amadori
Overview
Explore the profile of S Amadori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
203
Citations
1436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buccisano F, Maurillo L, Piciocchi A, Del Principe M, Picardi A, Cerretti R, et al.
Bone Marrow Transplant
. 2016 Dec;
52(3):473-475.
PMID: 27941782
No abstract available.
2.
Del Poeta G, Postorino M, Pupo L, Del Principe M, Dal Bo M, Bittolo T, et al.
Drugs Today (Barc)
. 2016 Jun;
52(4):249-60.
PMID: 27252989
Venetoclax (ABT-199) is a small-molecule selective oral inhibitor of the antiapoptotic protein Bcl-2 that promotes programmed cell death of chronic lymphocytic leukemia (CLL) cells regulating the release of proapoptotic factors,...
3.
Amadori S
Leuk Suppl
. 2016 May;
1(Suppl 2):S16-7.
PMID: 27175234
The treatment of older patients with acute myeloid leukemia is a difficult challenge. Older adults are more likely to have comorbidities that can limit treatment options, the disease tends to...
4.
Cicconi L, Divona M, Ciardi C, Ottone T, Ferrantini A, Lavorgna S, et al.
Leukemia
. 2016 May;
30(10):1987-1992.
PMID: 27133819
The APL0406 study showed that arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) are not inferior to standard ATRA and chemotherapy (CHT) in newly diagnosed, low-intermediaterisk acute promyelocytic leukaemia (APL)....
5.
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy
Postorino M, Pupo L, Provenzano I, Del Principe M, Buccisano F, Franceschini L, et al.
Ann Hematol
. 2015 Oct;
95(1):153-154.
PMID: 26442854
No abstract available.
6.
Buccisano F, Maurillo L, Piciocchi A, Del Principe M, Sarlo C, Cefalo M, et al.
Ann Hematol
. 2015 Apr;
94(8):1319-26.
PMID: 25869029
In the present analysis, we evaluated whether in elderly acute myeloid leukemia (AML) patients (>60 years), minimal residual disease (MRD) assessed by flow cytometry may have a role in guiding...
7.
Hengeveld M, Suciu S, Chelgoum Y, Marie J, Muus P, Lefrere F, et al.
Bone Marrow Transplant
. 2014 Nov;
50(3):341-7.
PMID: 25402418
The faster hematopoietic recovery after autologous peripheral blood SCT (APBSCT) in patients with AML may be offset by an increased relapse risk as compared with autologous BMT (ABMT). The EORTC...
8.
Willemze R, Suciu S, Muus P, Halkes C, Meloni G, Meert L, et al.
Ann Hematol
. 2014 Apr;
93(6):965-75.
PMID: 24682421
This study aims to determine the maximum tolerated dose (MTD) of clofarabine combined with the EORTC-GIMEMA 3 + 10 induction regimen (idarubicin + cytosine arabinoside) in adults with untreated acute...
9.
Amadori S, Bonetti E, Campari E, Cappelloni I, Montanari R
Mater Sci Eng C Mater Biol Appl
. 2013 Jul;
33(3):1455-9.
PMID: 23827595
This work describes the anelastic and dynamic Young modulus behaviour of human dentin from room temperature up to 673 K. Human molars, extracted from individuals (males 55-70 years old) as...
10.
Noguera N, Song M, Divona M, Catalano G, Calvo K, Garcia F, et al.
Leukemia
. 2012 Nov;
27(5):1037-43.
PMID: 23183427
PTEN (phosphatase and tensin homolog deleted in chromosome 10) is a bona fide dual lipid and protein phosphatase with cytoplasmic (Cy) and nuclear localization. PTEN nuclear exclusion has been associated...